Axogen (AXGN): Revenue Forecast to Grow 13.8% Annually Heading Into Earnings Season [Yahoo! Finance]
Axogen, Inc. (AXGN)
Last axogen, inc. earnings: 2/24 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.axogeninc.com
Company Research
Source: Yahoo! Finance
Looking ahead, analysts forecast revenue will grow 13.8% annually, outpacing the US market's 10.3% average growth. Sharp earnings growth of 123.3% per year is expected to drive profitability within the next three years. Investors are eyeing Axogen's substantial revenue growth potential and the inflection point to profitability as key themes in this earnings cycle. See our full analysis for Axogen. Next, we'll see how these headline figures hold up against the narratives investors are trading on, and where the story might take a new turn. See what the community is saying about Axogen NasdaqCM:AXGN Revenue & Expenses Breakdown as at Oct 2025 FDA Approval Could Secure 12-Year Market Exclusivity With an anticipated FDA Biologics License Application approval for Avance Nerve Graft in September 2025, Axogen expects to lock in 12 years of market exclusivity, bolstering its pricing power and limiting biosimilar competition. Analysts' consensus view highlights that this exclusivi
Show less
Read more
Impact Snapshot
Event Time:
AXGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AXGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AXGN alerts
High impacting Axogen, Inc. news events
Weekly update
A roundup of the hottest topics
AXGN
News
- AxoGen (NASDAQ:AXGN) was given a new $37.00 price target on by analysts at Canaccord Genuity Group Inc..MarketBeat
- AxoGen (NASDAQ:AXGN) had its "outperform" rating reaffirmed by analysts at Raymond James Financial, Inc..MarketBeat
- AxoGen (NASDAQ:AXGN) had its "buy" rating reaffirmed by analysts at Lake Street Capital.MarketBeat
- AxoGen (NASDAQ:AXGN) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..MarketBeat
- Axogen Announces FDA Approval of Biologics License Application for AVANCE® (acellular nerve allograft–arwx) [Yahoo! Finance]Yahoo! Finance
AXGN
Earnings
- 10/29/25 - Beat
AXGN
Sec Filings
- 12/4/25 - Form 8-K
- 11/14/25 - Form SCHEDULE
- 11/12/25 - Form 144
- AXGN's page on the SEC website